Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-034537

Director sold 15,000 shares at an average $148.95 ($2,234,266)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-12-16 Sale −914 $147.00 $134,360 6,734 D
Bolzon Bradley J PhD Director 2020-12-16 Sale −878 $147.00 $129,068 346,308 I
Bolzon Bradley J PhD Director 2020-12-16 Sale −2,679 $148.28 $397,245 4,055 D
Bolzon Bradley J PhD Director 2020-12-16 Sale −2,576 $148.28 $381,972 343,732 I
Bolzon Bradley J PhD Director 2020-12-16 Sale −2,091 $149.12 $311,815 1,964 D
Bolzon Bradley J PhD Director 2020-12-16 Sale −2,009 $149.12 $299,586 341,723 I
Bolzon Bradley J PhD Director 2020-12-16 Sale −995 $150.14 $149,392 969 D
Bolzon Bradley J PhD Director 2020-12-16 Sale −958 $150.14 $143,837 340,765 I
Bolzon Bradley J PhD Director 2020-12-16 Sale −969 $151.05 $146,365 0 D
Bolzon Bradley J PhD Director 2020-12-16 Sale −931 $151.05 $140,625 339,834 I
Open-market sales · 15,000 sh · avg $148.95 · $2,234,266
Loading xslF345X03/doc4.xml…